New paper on potential therapy against SARS-CoV-2
Updated: Dec 18, 2020
Check out our work on the ACE2 microbody as a potent inhibitor of the SARS-CoV-2 virus published in Cell Reports. Congratulations and Thanks to everyone who contributed!- Nimigean Lab, Stapleford Lab and Wilen Lab.
We were also featured in the NYU Langone Health NewsHub.